2026 Partnership Opportunities
As the only industry-driven summit focused on uniting Chief Executive Officers, Chief Scientific Officers, Chief Operating Officers, Chief Business Officers, Directors of Pharmaceutical Development and more, from companies such as Beyond Barriers Therapeutics, Seelos Therapeutics, Ceres Brain Therapeutics, Neuronasal, Eradivir, Via Therapeutics and more, this meeting is a must-attend.
Join us in 2026 to build meaningful connections with experts that are spearheading nasal drug development, hoping to pave new ways to accelerate speed to market with your assistance.
Collaborate with us in 2026 to create a bespoke partnership package that aligns with your preferences as:
CDMOs providing expert analytical services, regulatory support, clinical/commercial manufacturing and packaging and serialization
Device development & testing providers offering device design and prototyping, formulation compatibility testing, and manufacturing and scale-up
Formulation providers offering formulation development, analytical testing, compatibility testing and stability studies
Pre-clinical model suppliers offering animal models, in vivo testing, toxicology studies and regulatory support
We are keen to ensure you connect with the individuals you want, in the matter that suits you best. Whether through presentations, one-on-one meetings, booths, private dinners, take advantage of this opportunity to spotlight your solutions and achieve your business development objectives.
Through our bespoke partnership package, you can:
Demonstrate the benefits of your CDMO, device testing services, your formulation services, and pre-clinical models to C-suite nasal experts.
Present in-depth talks into your proven solutions and services to build exciting new partnerships with the leading nasal drug developers looking to optimize and accelerate their drug to market.
Who Would You Have Met in 2025?
Based on 2024's Novel Nasal Formulation & Delivery Summit
